Literature DB >> 29631355

Vimentin expression is required for the development of EMT-related renal fibrosis following unilateral ureteral obstruction in mice.

Zheng Wang1, Alex Divanyan1, Frances L Jourd'heuil1, Robert D Goldman2, Karen M Ridge3, David Jourd'heuil1, Reynold I Lopez-Soler4.   

Abstract

Most renal transplants ultimately fail secondary to chronic allograft nephropathy (CAN). Vimentin (vim) is a member of the intermediate filament family of proteins and has been shown to be important in the development of CAN. One of the pathways leading to chronic renal fibrosis after transplant is thought to be epithelial to mesenchymal transition (EMT). Even though vim expression is one of the main steps of EMT, it is unknown whether vim expression is required for EMT leading to renal fibrosis and allograft loss. To this end, the role of vim in renal fibrosis was determined via unilateral ureteral obstruction (UUO) in vim knockout mice (129 svs6 vim -/-). Following UUO, kidneys were recovered and analyzed via Western blotting, immunofluorescence, and transcriptomics. Cultured human proximal renal tubular (HK-2) cells were subjected to lentiviral-driven inhibition of vim expression and then treated with transforming growth factor (TGF)-β to undergo EMT. Immunoblotting as well as wound healing assays were used to determine development of EMT. Western blotting analyses of mice undergoing UUO reveal increased levels of vim soon after UUO. As expected, interstitial collagen deposition increased in control mice following UUO but decreased in vim -/- kidneys. Immunofluorescence analyses also revealed altered localization of β-catenin in vim -/- mice undergoing UUO without significant changes in mRNA levels. However, RNA sequencing revealed a decrease in β-catenin-dependent genes in vim -/- kidneys. Finally, vim-silenced HK-2 cell lines undergoing EMT were shown to have decreased cellular migration during wound healing. We conclude that vim inhibition decreases fibrosis following UUO by possibly altering β-catenin localization and downstream signaling.

Entities:  

Keywords:  CAN; EMT; fibrosis; renal transplant; vimentin; β-catenin

Mesh:

Substances:

Year:  2018        PMID: 29631355      PMCID: PMC6335003          DOI: 10.1152/ajprenal.00340.2017

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  58 in total

1.  A practical guide to evaluating colocalization in biological microscopy.

Authors:  Kenneth W Dunn; Malgorzata M Kamocka; John H McDonald
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-05       Impact factor: 4.249

2.  Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction.

Authors:  Akira Miyajima; Takeo Kosaka; Kaori Seta; Tomohiko Asano; Kazuo Umezawa; Masamachi Hayakawa
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

3.  Calyculin A-induced vimentin phosphorylation sequesters 14-3-3 and displaces other 14-3-3 partners in vivo.

Authors:  G Tzivion; Z J Luo; J Avruch
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

4.  Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition.

Authors:  Melissa G Mendez; Shin-Ichiro Kojima; Robert D Goldman
Journal:  FASEB J       Date:  2010-01-22       Impact factor: 5.191

5.  Recovery of Na-glucose cotransport activity after renal ischemia is impaired in mice lacking vimentin.

Authors:  Isabelle Runembert; Sylviane Couette; Pierre Federici; Emma Colucci-Guyon; Charles Babinet; Pascale Briand; Gérard Friedlander; Fabiola Terzi
Journal:  Am J Physiol Renal Physiol       Date:  2004-07-06

Review 6.  Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis.

Authors:  Surmeet Bedi; Aparna Vidyasagar; Arjang Djamali
Journal:  Transplant Rev (Orlando)       Date:  2008-01       Impact factor: 3.943

7.  Tubular expression of heat-shock protein 27 inhibits fibrogenesis in obstructive nephropathy.

Authors:  Aparna Vidyasagar; Shannon R Reese; Omeed Hafez; Ling-Jin Huang; William F Swain; Lynn M Jacobson; Jose R Torrealba; Pierre-Emmanuel Chammas; Nancy A Wilson; Arjang Djamali
Journal:  Kidney Int       Date:  2012-09-12       Impact factor: 10.612

8.  Plectin reinforces vascular integrity by mediating crosstalk between the vimentin and the actin networks.

Authors:  Selma Osmanagic-Myers; Stefanie Rus; Michael Wolfram; Daniela Brunner; Wolfgang H Goldmann; Navid Bonakdar; Irmgard Fischer; Siegfried Reipert; Aurora Zuzuarregui; Gernot Walko; Gerhard Wiche
Journal:  J Cell Sci       Date:  2015-10-30       Impact factor: 5.285

9.  Platelet-rich plasma inhibits RANKL-induced osteoclast differentiation through activation of Wnt pathway during bone remodeling.

Authors:  Dongyue Wang; Yajuan Weng; Shuyu Guo; Yuxin Zhang; Tingting Zhou; Mengnan Zhang; Lin Wang; Junqing Ma
Journal:  Int J Mol Med       Date:  2017-11-16       Impact factor: 4.101

10.  E-cadherin dynamics is regulated by galectin-7 at epithelial cell surface.

Authors:  Tamara Advedissian; Véronique Proux-Gillardeaux; Rachel Nkosi; Grégoire Peyret; Thao Nguyen; Françoise Poirier; Mireille Viguier; Frédérique Deshayes
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

View more
  16 in total

1.  Shroom3, a Gene Associated with CKD, Modulates Epithelial Recovery after AKI.

Authors:  Aihua Li; Joanna Cunanan; Hadiseh Khalili; Timothy Plageman; Kjetil Ask; Ahsan Khan; Ashmeet Hunjan; Thomas Drysdale; Darren Bridgewater
Journal:  Kidney360       Date:  2021-11-03

2.  Soft, Dynamic Hydrogel Confinement Improves Kidney Organoid Lumen Morphology and Reduces Epithelial-Mesenchymal Transition in Culture.

Authors:  Floor A A Ruiter; Francis L C Morgan; Nadia Roumans; Anika Schumacher; Gisela G Slaats; Lorenzo Moroni; Vanessa L S LaPointe; Matthew B Baker
Journal:  Adv Sci (Weinh)       Date:  2022-05-14       Impact factor: 17.521

3.  UT-A1/A3 knockout mice show reduced fibrosis following unilateral ureteral obstruction.

Authors:  Fitra Rianto; Akihiro Kuma; Carla L Ellis; Faten Hassounah; Eva L Rodriguez; Xiaonan H Wang; Jeff M Sands; Janet D Klein
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-16

4.  Higher intestinal and circulatory lactate associated NOX2 activation leads to an ectopic fibrotic pathology following microcystin co-exposure in murine fatty liver disease.

Authors:  Sutapa Sarkar; Punnag Saha; Ratanesh K Seth; Ayan Mondal; Dipro Bose; Diana Kimono; Muayad Albadrani; Avik Mukherjee; Dwayne E Porter; Geoff I Scott; Shuo Xiao; Bryan Brooks; John Ferry; Mitzi Nagarkatti; Prakash Nagarkatti; Saurabh Chatterjee
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2020-08-08       Impact factor: 3.228

Review 5.  Vimentin on the move: new developments in cell migration.

Authors:  Rachel A Battaglia; Samed Delic; Harald Herrmann; Natasha T Snider
Journal:  F1000Res       Date:  2018-11-15

6.  Osthole Ameliorates Renal Fibrosis in Mice by Suppressing Fibroblast Activation and Epithelial-Mesenchymal Transition.

Authors:  Suping Zhang; Qian Huang; Xiaoxia Cai; Shan Jiang; Nan Xu; Qin Zhou; Xiaoyun Cao; Michael Hultström; Jiong Tian; En Yin Lai
Journal:  Front Physiol       Date:  2018-11-21       Impact factor: 4.566

7.  Lens Epithelial Cells Initiate an Inflammatory Response Following Cataract Surgery.

Authors:  Jian Jiang; Mahbubul H Shihan; Yan Wang; Melinda K Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-10-01       Impact factor: 4.799

Review 8.  Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections.

Authors:  Irene Ramos; Konstantinos Stamatakis; Clara L Oeste; Dolores Pérez-Sala
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

9.  PM2.5 Induces Early Epithelial Mesenchymal Transition in Human Proximal Tubular Epithelial Cells through Activation of IL-6/STAT3 Pathway.

Authors:  Chien-Hung Lin; Chuan Wan; Wen-Sheng Liu; Hsin-Hui Wang
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

10.  Early Renoprotective Effect of Ruxolitinib in a Rat Model of Diabetic Nephropathy.

Authors:  Mohamed M El-Kady; Reham A Naggar; Maha Guimei; Iman M Talaat; Olfat G Shaker; Maha Saber-Ayad
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.